tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market
AMRX
Amneal Pharmaceuticals
RESEARCH TOOLSreports
Want to see AMRX full AI Analyst Report?

Amneal Pharmaceuticals (AMRX) Ratios

604 Followers

Amneal Pharmaceuticals Ratios

AMRX's free cash flow for Q4 2025 was $0.36. For the 2025 fiscal year, AMRX's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.17 2.17 1.41 1.63 1.88
Quick Ratio
 1.48 1.48 0.86 0.94 1.17
Cash Ratio
 0.35 0.35 0.10 0.11 0.03
Solvency Ratio
 0.06 0.08 0.03 0.04 0.03
Operating Cash Flow Ratio
 0.39 0.39 0.26 0.41 0.09
Short-Term Operating Cash Flow Coverage
 15.76 15.76 0.91 1.62 0.72
Net Current Asset Value
$ -1.76B$ -1.76B$ -1.96B$ -2.03B$ -2.18B
Leverage Ratios
Debt-to-Assets Ratio
 0.74 0.74 0.74 0.79 0.75
Debt-to-Equity Ratio
 -38.65 -38.65 -23.73 139.05 9.53
Debt-to-Capital Ratio
 1.03 1.03 1.04 0.99 0.91
Long-Term Debt-to-Capital Ratio
 1.03 1.03 1.05 0.99 0.90
Financial Leverage Ratio
 -51.96 -51.96 -32.04 175.55 12.73
Debt Service Coverage Ratio
 2.17 2.26 0.72 1.16 1.75
Interest Coverage Ratio
 1.22 1.75 0.96 0.97 -0.60
Debt to Market Cap
 0.66 0.67 1.02 2.49 9.06
Interest Debt Per Share
 8.88 9.50 9.23 16.92 19.90
Net Debt to EBITDA
 5.40 4.02 5.65 5.31 6.40
Profitability Margins
Gross Profit Margin
36.90%37.63%36.52%36.09%35.78%
EBIT Margin
12.30%12.60%7.29%11.34%9.04%
EBITDA Margin
19.34%20.00%15.74%20.92%19.90%
Operating Profit Margin
9.72%14.02%8.92%8.54%-4.29%
Pretax Profit Margin
3.79%4.61%-1.97%-1.68%-11.22%
Net Profit Margin
1.90%2.39%-4.18%-3.51%-5.88%
Continuous Operations Profit Margin
3.77%4.24%-2.64%-2.04%-11.52%
Net Income Per EBT
50.05%51.76%212.47%208.57%52.39%
EBT Per EBIT
39.05%32.90%-22.06%-19.70%261.38%
Return on Assets (ROA)
1.20%1.96%-3.34%-2.42%-3.42%
Return on Equity (ROE)
-41.58%-101.78%106.97%-424.61%-43.56%
Return on Capital Employed (ROCE)
8.07%15.13%10.51%7.78%-3.12%
Return on Invested Capital (ROIC)
7.96%13.80%9.19%7.16%-3.01%
Return on Tangible Assets
1.75%2.86%-5.38%-4.23%-6.18%
Earnings Yield
1.07%1.82%-4.78%-7.91%-43.27%
Efficiency Ratios
Receivables Turnover
 2.47 3.21 3.60 3.71 2.98
Payables Turnover
 5.76 7.39 6.83 10.65 8.52
Inventory Turnover
 2.42 3.11 2.90 2.63 2.68
Fixed Asset Turnover
 4.22 5.49 5.34 4.35 3.75
Asset Turnover
 0.63 0.82 0.80 0.69 0.58
Working Capital Turnover Ratio
 2.32 4.06 5.65 4.02 2.95
Cash Conversion Cycle
 235.21 181.81 173.91 202.92 215.87
Days of Sales Outstanding
 147.66 113.64 101.34 98.46 122.39
Days of Inventory Outstanding
 150.96 117.55 126.05 138.72 136.34
Days of Payables Outstanding
 63.41 49.37 53.48 34.26 42.86
Operating Cycle
 298.62 231.19 227.39 237.18 258.73
Cash Flow Ratios
Operating Cash Flow Per Share
 1.03 1.08 0.96 1.97 0.43
Free Cash Flow Per Share
 0.72 0.86 0.71 1.58 -0.17
CapEx Per Share
 0.31 0.22 0.24 0.40 0.60
Free Cash Flow to Operating Cash Flow
 0.70 0.79 0.75 0.80 -0.39
Dividend Paid and CapEx Coverage Ratio
 3.30 4.85 3.94 4.99 0.72
Capital Expenditure Coverage Ratio
 3.30 4.85 3.94 4.99 0.72
Operating Cash Flow Coverage Ratio
 0.12 0.12 0.11 0.13 0.02
Operating Cash Flow to Sales Ratio
 0.15 0.11 0.11 0.14 0.03
Free Cash Flow Yield
5.91%6.84%8.99%26.02%-8.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 93.35 54.80 -20.94 -12.65 -2.31
Price-to-Sales (P/S) Ratio
 1.72 1.31 0.88 0.44 0.14
Price-to-Book (P/B) Ratio
 -58.17 -55.77 -22.40 53.70 1.01
Price-to-Free Cash Flow (P/FCF) Ratio
 16.86 14.63 11.12 3.84 -11.78
Price-to-Operating Cash Flow Ratio
 12.11 11.61 8.29 3.07 4.61
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.34 1.00 0.29 <0.01
Price-to-Fair Value
 -58.17 -55.77 -22.40 53.70 1.01
Enterprise Value Multiple
 14.29 10.56 11.21 7.43 7.09
Enterprise Value
 6.44B 6.37B 4.93B 3.72B 3.12B
EV to EBITDA
 14.32 10.56 11.21 7.43 7.09
EV to Sales
 2.77 2.11 1.76 1.55 1.41
EV to Free Cash Flow
 27.16 23.61 22.40 13.46 -122.36
EV to Operating Cash Flow
 18.93 18.75 16.71 10.77 47.92
Tangible Book Value Per Share
 -3.51 -3.68 -4.45 -8.16 -9.84
Shareholders’ Equity Per Share
 -0.22 -0.23 -0.35 0.11 1.98
Tax and Other Ratios
Effective Tax Rate
 <0.01 0.08 -0.34 -0.21 -0.03
Revenue Per Share
 7.06 9.63 9.04 13.68 14.66
Net Income Per Share
 0.13 0.23 -0.38 -0.48 -0.86
Tax Burden
 0.50 0.52 2.12 2.09 0.52
Interest Burden
 0.31 0.37 -0.27 -0.15 -1.24
Research & Development to Revenue
 0.06 0.06 0.07 0.08 0.09
SG&A to Revenue
 0.18 0.17 0.17 0.17 0.17
Stock-Based Compensation to Revenue
 0.01 0.01 <0.01 0.01 0.01
Income Quality
 2.66 4.72 -3.99 -7.09 -0.26
Currency in USD